Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31716946 | 0.89 | LMNA (0.44) | KDM4ELMNAROCK2MAPK1RNASEH1 | |
| SCHEMBL31716050 | 0.86 | LMNA (0.43) | KDM4ELMNAROCK2MAPK1RNASEH1 | |
| SCHEMBL31716260 | 0.84 | PDE5A (0.36) | KDM4ELMNANPC1RAB9AROCK2 | |
| SCHEMBL31716882 | 0.82 | MAPK1 (0.46) | KDM4ELMNAROCK2MAPK1PDE10A | |
| SCHEMBL31717042 | 0.81 | LMNA (0.43) | KDM4ELMNAROCK2MAPK1RNASEH1 | |
| SCHEMBL31716933 | 0.80 | LMNA (0.43) | KDM4ELMNAROCK2MAPK1RNASEH1 | |
| SCHEMBL31716955 | 0.79 | LMNA (0.43) | KDM4ELMNAROCK2MAPK1GAA | |
| SCHEMBL31715980 | 0.79 | LMNA (0.42) | KDM4ELMNAROCK2MAPK1PDE10A | |
| SCHEMBL31715976 | 0.77 | KDM4E (0.49) | KDM4ELMNAROCK2ROCK1KMT2A | |
| SCHEMBL31716019 | 0.77 | PDE5A (0.38) | KDM4ELMNAROCK2ROCK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227032-A1 | METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES | REMIX THERAPEUTICS INC. (US) | 2025-10-30 | — | — | WO | disclosed |